医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Jack Ma Foundation and Alibaba Foundation Announce Donations to Four Southeast Asian Countries

2020年03月19日 PM09:58
このエントリーをはてなブックマークに追加


 

HANGZHOU, China

The Jack Ma Foundation and Alibaba Foundation today announced donations of medical supplies to four Southeast Asian countries.

The foundations have been able to reach out to the governments of Malaysia, Indonesia, Thailand and the Philippines and propose the donation of medical supplies. The foundations’ goal is to aid the fight against the COVID-19 virus in these nations, with more support for other neighboring countries to follow.

“We join hands with our Asian neighbors to fight COVID-19,” said the Jack Ma Foundation when announcing the donation to the four countries. “We and Alibaba Foundation will send 2 million masks, 150,000 test kits, 20,000 protective suits and 20,000 face shields to Indonesia, Malaysia, the Philippines and Thailand. More help to other Asian nations is on the way! Go Asia!”

The foundation donations follow Wednesday’s release of a digital handbook they supported. It shares key lessons and experience from doctors and other medical administrators and staff at a Chinese hospital at the frontline of COVID-19 treatment and crucial to slowing its spread.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200319005410/en/

CONTACT

Rico Ngai (Southeast Asia)

Alibaba Group

+852 9725 9600

rico.ngai@alibaba-inc.com

Adam Najberg (International)

Alibaba Group

+852 5474 3262

adam.najberg@alibaba-inc.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease